DAY 3 ✦ 4 Nov 2026Wednesday, 4 November 2026 - Europe/Lisbon

Measurement remains one of the most persistent challenges in pharmaceutical meetings and events. Attention turns to defining meaningful objectives, capturing quality data, integrating platforms, and translating insights into demonstrable value for leadership and stakeholders.

• Define success metrics aligned to strategic goals and leadership expectations

• Improve data capture and integration across tools, platforms, and CRMs

• Apply post‑event insights to demonstrate value and inform future planning

Procurement processes continue to evolve, often creating misalignment between planners, procurement teams, and service providers. Focus areas include MSAs, RFP complexity, contracting challenges, talent investment, and defining value beyond cost.

• Diagnose friction points between planners, procurement teams, and suppliers

• Strengthen alignment around MSAs, RFP processes, and contracting practices

• Articulate the strategic value of expertise, talent, and partnership investment

Compliance remains one of the most critical and complex aspects of pharmaceutical meetings. Exploration centers on technology enablement, process efficiency, platform integration, risk management, and striking the right balance between governance and business enablement.

• Prioritize compliance risks across multi‑market meetings and events

• Streamline approval workflows through smarter technology integration

• Maintain audit‑readiness while reducing friction in planning processes

Security is becoming a foundational consideration across the entire meeting planning lifecycle. From global risk assessments to attendee perceptions of safety, discussions focus on preparedness, mitigation strategies, and integrating security into planning processes without compromising experience.

• Anticipate emerging safety and security risks affecting global meetings

• Integrate security considerations across the full planning lifecycle

• Strengthen attendee confidence through visible and effective risk management

As pharmaceutical meetings become more regulated, data‑driven, and technology‑enabled, the role of the meeting professional is evolving rapidly. The focus turns to how organizations and partners are redefining planner roles, capabilities, and career paths to keep pace with AI, rising risk exposure, procurement pressure, and increasing stakeholder expectations—while preserving the human judgement, expertise, and leadership that underpin successful and compliant meetings.

• How planner roles are shifting from execution to strategic advisory, orchestration, and risk ownership

• The critical skills and capabilities needed next, from data literacy and AI fluency to influence, business acumen, and decision‑making under uncertainty

• Practical approaches to talent development, resourcing, and wellbeing that support retention, performance, and long‑term sustainability